{
    "nct_id": "NCT04186819",
    "official_title": "A Prospective, Phase 3, Multi Center, Single-arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) Ligand in Men With Newly Diagnosed Prostate Cancer",
    "inclusion_criteria": "1. Patient is male and aged >18 years old.\n2. Histologically confirmed adenocarcinoma of the prostate.\n3. Patients electing to undergo Radical Prostatectomy (RP) with Pelvic lymph node dissection (PLND).\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Patients who are planned to have an x-ray contrast agent or other PET radiotracer <24 hours prior to the PET scan.\n2. Patients currently receiving, or with a prior history of, Androgen Deprivation Therapy (ADT).",
    "miscellaneous_criteria": ""
}